DNA methylome in HER2-positive resistant breast cancer 

    Palomeras, Sònia (Date of defense: 2019-02-27)

    The major clinical problem for HER2+ breast cancer target therapies is the acquisition of resistance. The DNA methylation status of the promoter gene region has been described as a common epigenetic alteration for ...